Daniel Associates
26
JUN
2017

Global Pain Management Therapeutics Market: High Prevalence of Chronic Diseases to Aid Growth

Posted By :
Comments : 0

The competition in the global pain management therapeutics market is intense owing to the presence of leading players with diversified products.. The market is expected to be highly saturated in the coming years owing to the high presence of conventional medicines accounting for over two-third of the global market for pain management therapeutics. Due to this several medium scale and small generic manufacturers of drugs are likely to venture into the market and make it highly competitive in the near future. The leading companies functional in the market are Purdue Pharma LP, Johnson & Johnson, Endo Health Solutions, Pfizer Inc., and Merck & Co. Inc. The top two players in the market, Purdue Pharma LP and Pfizer Inc. held a share for above 50% in the global pain management therapeutics market in 2015. In the coming years, the share of the core vendors is expected to decline owing to the emergence of new players such as AstraZeneca Plc. and Depomed Inc.

According to a DA researcher, “The global market for pain management therapeutics is expected to rise at a moderate CAGR of 3.7% from 2016 to 2022. In 2016, the market was valued at US$62.2 bn and is expected to be worth US$74.61 bn by the end of 2022.”

Cancer Pain Medication to Top List

According to the World Health Organization, the number of new registered cancer cases worldwide was approximately 14 million. Moreover, in the coming two decades, cancer cases across the globe are likely to rise by over 70% across the globe. The extensive rise in the cases of cancer in the last couple of years, makes it one of the core drivers for the growth of the market and a key stimulator for the future opportunities. In 2016, the segment of cancer pain management held a share of 28% in the global market for pain management therapeutics market and is likely to maintain the dominant position in the coming years. The segment that is expected to witness the most promising growth is back pain owing to the rigid and sedentary lifestyles of people across the globe.

Region-wise, the global market or pain management therapeutics has been segmented into Asia Pacific, Europe, North America, and the Rest of the World. The leading regions in the market in 2016 were North America and Europe with a collective share of 80% and Asia Pacific taking the third place. The growth of the market in North America can be attributed to the excellent healthcare infrastructure and extensive consumption of high-end pain management drugs. The country that held the leading position in the North America pain management market is the U.S. Asia Pacific is further expected to present lucrative growth opportunities owing to growing investments by governments and players in the healthcare industry and strengthening economies. Growing affordability of people and launch of novel products are further expected to play a crucial part here.

Growing Geriatric Population to Have Positive Impact on Market

The extensive rise in the geriatric population across the globe is a factor that has significantly advanced the adoption of pain management therapeutics in the recent years. As old people are more disposed to diseases such as diabetic neuropathy, nerve damage, depression, epilepsy, bone or joint pain, arthritis, and other injuries due to low immunity, the use of pain management therapeutics is more among them. The rising number of patients suffering chronic diseases has further encouraged the use of pain management therapeutics. Moreover, favorable policies by the governments in various countries is also anticipated to aid in the growth of the market in the years ahead.

Pain Management Therapeutics Market (Therapeutics – Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic; Indication – Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain, Cancer Pain) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2022

The market is segmented as follows:

Global Pain Management Therapeutics Market Revenue, by Therapeutics

  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Opioids
    • Oxycodones
    • Hydrocodones
    • Tramadol
    • Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
  • Antimigraine Agents
  • Other Non-narcotic Analgesic

Global Pain Management Therapeutics Market Revenue, by Indication

  • Neuropathic Pain
  • Fibromyalgia
  • Chronic Back Pain
  • Arthritic Pain
  • Migraine
  • Post-operative Pain
  • Cancer Pain

Global Pain Management Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific (APAC)
    • China
    • Japan
  • Rest of the World (RoW)
    • Brazil
    • Mexico

 

 

About Daniel Associates

DANIEL ASSOCIATES is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our fulltime/part-time analyst and SMEs at Daniel Associates are tracking global high growth markets following the “Growth Engagement Model”. It aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

The new included chapters on Methodology and Benchmarking presented with high quality analytical info graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at Daniel Associates are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Daniel Associates

Email: info@danielassociate.com

 

About the Author

Leave a Reply

*

captcha *